| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 178 | 2021 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 93 | 2022 |
| Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies E Olmastroni, G Molari, N De Beni, O Colpani, F Galimberti, M Gazzotti, ... European journal of preventive cardiology, 2021 | 63 | 2021 |
| Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of … M Casula, E Olmastroni, M Gazzotti, F Galimberti, A Zambon, ... Pharmacological Research, 105060, 2020 | 48 | 2020 |
| Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study M Casula, M Gazzotti, F Bonaiti, E OImastroni, M Arca, M Averna, ... Journal of internal medicine 290 (1), 116-128, 2021 | 27 | 2021 |
| Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With … E Olmastroni, M Gazzotti, M Arca, M Averna, A Pirillo, AL Catapano, ... Journal of the American Heart Association, e023668, 2022 | 15 | 2022 |
| How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia M Gazzotti, M Casula, E Olmastroni, M Averna, M Arca, AL Catapano Atherosclerosis Supplements 42, e35-e40, 2020 | 14 | 2020 |
| Lipoprotein (a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group C Pederiva, ME Capra, G Biasucci, G Banderali, E Fabrizi, M Gazzotti, ... Atherosclerosis, 2022 | 13 | 2022 |
| Evaluation of lipoprotein (a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network AL Catapano, L Tokgözoğlu, M Banach, M Gazzotti, E Olmastroni, ... Atherosclerosis 370, 5-11, 2023 | 9 | 2023 |
| REFINEMENT OF PATHOGENICITY CLASSIFICATION OF VARIANTS ASSOCIATED WITH FAMILIAL HYPERCHOLESTEROLEMIA: IMPLICATIONS FOR CLINICAL DIAGNOSIS A Di Costanzo, I Minicocci, L D'Erasmo, D Commodari, S Covino, S Bini, ... Journal of Clinical Lipidology, 2021 | 8 | 2021 |
| Lipoprotein (a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia E Olmastroni, M Gazzotti, M Averna, M Arca, P Tarugi, S Calandra, ... Journal of the American Heart Association 12 (10), e029223, 2023 | 6 | 2023 |
| The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group M Gazzotti, M Casula, S Bertolini, ME Capra, E Olmastroni, AL Catapano, ... Frontiers in genetics 13, 2022 | 5 | 2022 |
| Achilles tendon ultrasonography in familial hypercholesterolemia: A sub-study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) A Baragetti, M Casula, P Scarinzi, F Ristè, R Scicali, M Biolo, S Lugari, ... Wiley, 2021 | 5 | 2021 |
| Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study M Casula, M Gazzotti, ME Capra, E Olmastroni, F Galimberti, ... Atherosclerosis, 117231, 2023 | 3 | 2023 |
| Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study. M Casula, M Gazzotti, F Bonaiti, E OImastroni, M Arca, M Averna, ... Journal of Internal Medicine 290 (1), 116-128, 2020 | 2 | 2020 |
| Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries A Alieva, A Di Costanzo, M Gazzotti, O Reutova, E Usova, V Bakaleiko, ... European Journal of Internal Medicine, 2024 | 1 | 2024 |
| Diagnostic criteria in children and adolescents affected by familial hypercholesterolemia in the Italian lipigen paediatric group M Gazzotti, E Olmastroni, C Pederiva, ME Capra, AL Catapano, M Casula Atherosclerosis 331, e49, 2021 | 1 | 2021 |
| Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group C Pederiva, M Gazzotti, M Arca, M Averna, G Banderali, G Biasucci, ... Nutrients 15 (15), 3468, 2023 | | 2023 |
| Does the lipoprotein (A) genotype influence the diagnosis of familial hypercholesterolemia? M Casula, E Olmastroni, M Gazzotti, A Catapano Atherosclerosis 379, S19, 2023 | | 2023 |
| FGF-5 uniquely identifies subjects with heterozygous familial hypercholesterolemia: Results from a proteomics study A Baragetti, E Mattavelli, A Alieva, M Gazzotti, F Pellegatta, L Grigore, ... Atherosclerosis 379, S14-S15, 2023 | | 2023 |
